In the study of esophageal squamous cell carcinoma, CAFs promote tumor cell growth by secreting plasminogen activator inhibitor-1 (PAI-1) and attenuate the therapeutic sensitivity of cisplatin (111). Here, SERPINE1 is linked to esophageal squamous cell carcinoma.